Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Taglich Covering Reliv Common Stock
February 3, 2003
1 Min Read
Taglich Covering Reliv Common Stock
CHESTERFIELD, Mo.--Taglich Brothers Inc., a NewYork-based brokerage firm, reinitiated coverage for Reliv International's (NASDAQ:RELV)common stock. As of Nov. 20, the firm had assigned the rating of"Speculative Buy" to the nutritional supplement company, setting a12-month price target of $7.68 per share.
You May Also Like